Abstract
The transcription factor Yin Yang 1 (YY1) (also known as NF-E1, δ, CP-1 and UCRBP) is a GLI-Kruppel zinc finger protein. 1–4YY1 is highly conserved from Xenopus to mammalian YY1 and has been demonstrated to play an essential role in mouse embryonic development and other physiological and pathological conditions.5, 6 As one of the first mammalian transcription factors that have been identified to possess both repression and activation activities, YY1 has served as a model for understanding how a single molecule can conduct opposite transcriptional functions, that is, repression and activation. Recent studies suggest that YY1 is a mammalian counterpart of the Drosophila Polycomb Group (PcG) protein Pleiohomeotic (Pho),7, 8 providing a new framework in which to further explore YY1’s biological functions and mechanism of action in vivo. In this chapter, we discuss progress on YY1 since its discovery.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Shi Y, Seto E, Chang LS et al. Transcriptional repression by YY1, a human GL1-Kruppel-related protein, and relief of repression by adenovirus E1A protein. Cell 1991; 67:377–88.
Park K, Atchison ML. Isolation of a candidate repressor/activator, NF-E1 (YY-1, delta), that binds to the immunoglobulin kappa 3′ enhancer and the immunoglobulin heavy-chain mu E1 site. Proc Natl Acad Sci USA 1991; 88:9804–8.
Hariharan N, Kelley DE, Perry RP. Delta, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein. Proceedings of the National Academy of Sciences of the United States of America 1991; 88:9799–803.
Flanagan JR, Becker KG, Ennist DL et al. Cloning of a negative transcription factor that binds to the upstream conserved region of Moloney murine leukemia virus. Molecular & Cellular Biology 1992; 12:38–44.
Shi Y, Lee JS, Galvin KM. Everything you have ever wanted to know about Yin Yang 1. Biochim Biophys Acta 1997; 1332:F49–66.
Donohoe ME, Zhang X, McGinnis L et al. Targeted disruption of mouse Yin Yang 1 transcription factor results in peri-implantation lethality. Mol Cell Biol 1999; 19:7237–44.
Atchison L, Ghias A, Wilkinson F et al. Transcription factor YY1 functions as a PcG protein in vivo. Embo J 2003; 22:1347–58.
Brown JL, Mucci D, Whiteley M et al. The Drosophila Polycomb group gene pleiohomeotic encodes a DNA binding protein with homology to the transcription factor YY1. [comment]. Molecular Cell 1998; 1:1057–64.
Pisaneschi G, Ceccotti S, Falchetti ML et al. Characterization of FIII/YY1, a Xenopus laevis conserved zinc-finger protein binding to the first exon of L1 and L14 ribosomal protein genes. Biochem Biophys Res Commun 1994; 205:1236–42.
Chen KS, Paladugu A, Aldaz CM et al. Cloning and chromosomal localization of the rat Stat5 and Yy1 genes. Cytogenet Cell Genet 1996; 74:277–80.
Sulston JE, Waterston R. Toward a complete human genome sequence. Genome Res 1998; 8:1097–108.
Hosler BA, LaRosa GJ, Grippo JF et al. Expression of REX-1, a gene containing zinc finger motifs, is rapidly reduced by retinoic acid in F9 teratocarcinoma cells. Molecular & Cellular Biology 1989; 9:5623–9.
Nishiguchi S, Joh T, Horie K et al. A survey of genes expressed in undifferentiated mouse embryonal carcinoma F9 cells: Characterization of low-abundance mRNAs. Journal of Biochemistry 1994; 116:128–39.
Scherer CA, Chen J, Nachabeh A et al. Transcriptional specificity of the pluripotent embryonic stem cell. Cell Growth & Differentiation 1996; 7:1393–401.
Ramalho-Santos M, Yoon S, Matsuzaki Y et al. “Stemness”: Transcriptional profiling of embryonic and adult stem cells. Science 2002; 298:597–600.
Yao YL, Dupont BR, Ghosh S et al. Cloning, chromosomal localization and promoter analysis of the human transcription factor YY1. Nucleic Acids Res 1998; 26:3776–83.
Zhu W, Lossie AC, Camper SA et al. Chromosomal localization of the transcription factor YY1 in the mouse and human. Mamm Genome 1994; 5:234–6.
Nishiyama C, Yokota T, Nishiyama M et al. Molecular cloning of rat transcription factor YY1. Biosci Biotechnol Biochem 2003; 67:654–8.
Brown JL, Fritsch C, Mueller J et al. The Drosophila pho-like gene encodes a YY1-related DNA binding protein that is redundant with pleiohomeotic in homeotic gene silencing. Development 2003; 130:285–94.
Hosler BA, Rogers MB, Kozak CA et al. An octamer motif contributes to the expression of the retinoic acid-regulated zinc finger gene Rex-1 (Zfp-42) in F9 teratocarcinoma cells. Molecular & Cellular Biology 1993; 13:2919–28.
Yao YL, Yang WM, Seto E. Regulation of transcription factor YY1 by acetylation and deacetylation. Mol Cell Biol 2001; 21:5979–91.
Austen M, Luscher B, Luscher-Firzlaff JM. Characterization of the transcriptional regulator YY1. The bipartite transactivation domain is independent of interaction with the TATA box-binding protein, transcription factor IIB, TAFII55, or cAMP-responsive element-binding protein (CPB)-binding protein. J Biol Chem 1997; 272:1709–17.
Xiao H, Friesen JD, Lis JT. A highly conserved domain of RNA polymerase II shares a functional element with acidic activation domains of upstream transcription factors. Molecular & Cellular Biology 1994; 14:7507–16.
Brou C, Wu J, Ali S et al. Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor. Nucleic Acids Research 1993; 21:5–12.
Defossez PA, Baert JL, Monnot M et al. The ETS family member ERM contains an alpha-helical acidic activation domain that contacts TAFII60. Nucleic Acids Research 1997; 25:4455–63.
Kim TK, Roeder RG. Proline-rich activator CTF1 targets the TFIIB assembly step during transcriptional activation. Proceedings of the National Academy of Sciences of the United States of America 1994; 91:4170–4.
Bushmeyer S, Park K, Atchison ML. Characterization of functional domains within the multifunctional transcription factor, YY1. J Biol Chem 1995; 270:30213–20.
Lee JS, See RH, Galvin KM et al. Functional interactions between YY1 and adenovirus E1A. Nucleic Acids Res 1995; 23:925–31.
Yant SR, Zhu W, Millinoff D et al. High affinity YY1 binding motifs: Identification of two core types (ACAT and CCAT) and distribution of potential binding sites within the human beta globin cluster. Nucleic Acids Res 1995; 23:4353–62.
Hyde-DeRuyscher RP, Jennings E, Shenk T. DNA binding sites for the transcriptional activator/repressor YY1. Nucleic Acids Res 1995; 23:4457–65.
Houbaviy HB, Usheva A, Shenk T et al. Cocrystal structure of YY1 bound to the adeno-associated virus P5 initiator. Proc Natl Acad Sci USA 1996; 93:13577–82.
Ma SL, Lovmand J, Sorensen AB et al. Triple basepair changes within and adjacent to the conserved YY1 motif upstream of the U3 enhancer repeats of SL3-3 murine leukemia virus cause a small but significant shortening of latency of T-lymphoma induction. Virology 2003; 313:638–44.
Sitwala KV, Adams K, Markovitz DM. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter. Oncogene 2002; 21:8862–70.
Raval-Pandya M, Dhawan P, Barletta F et al. YY1 represses vitamin D receptor-mediated 25-hydroxyvitamin D(3)24-hydroxylase transcription: Relief of repression by CREB-binding protein. Mol Endocrinol 2001; 15:1035–46.
Satyamoorthy K, Park K, Atchison ML et al. The intracisternal A-particle upstream element interacts with transcription factor YY1 to activate transcription: Pleiotropic effects of YY1 on distinct DNA promoter elements. Mol Cell Biol 1993; 13:6621–8.
L’Honore A, Lamb NJ, Vandromme M et al. MyoD distal regulatory region contains an SRF binding CArG element required for MyoD expression in skeletal myoblasts and during muscle regeneration. Mol Biol Cell 2003; 14:2151–62.
McNeil S, Guo B, Stein JL et al. Targeting of the YY1 transcription factor to the nucleolus and the nuclear matrix in situ: The C-terminus is a principal determinant for nuclear trafficking. J Cell Biochem 1998; 68:500–10.
Guo B, Odgren PR, van Wijnen AJ et al. The nuclear matrix protein NMP-1 is the transcription factor YY1. Proc Natl Acad Sci USA 1995; 92:10526–30.
Inouye CJ, Seto E. Relief of YY1-induced transcriptional repression by protein-protein interaction with the nucleolar phosphoprotein B23. J Biol Chem 1994; 269:6506–10.
Bushmeyer SM, Atchison ML. Identification of YY1 sequences necessary for association with the nuclear matrix and for transcriptional repression functions. J Cell Biochem 1998; 68:484–99.
Chan PK, Chan FY, Morris SW et al. Isolation and characterization of the human nucleophosmin/B23 (NPM) gene: Identification of the YY1 binding site at the 5′ enhancer region. Nucleic Acids Res 1997; 25:1225–32.
Ficzycz A, Eskiw C, Meyer D et al. Expression, activity, and subcellular localization of the Yin Yang 1 transcription factor in Xenopus oocytes and embryos. J Biol Chem 2001; 276:22819–25.
Ficzycz A, Ovsenek N. The Yin Yang 1 transcription factor associates with ribonucleoprotein (mRNP) complexes in the cytoplasm of Xenopus oocytes. J Biol Chem 2002; 277:8382–7.
Thomas MJ, Seto E. Unlocking the mechanisms of transcription factor YY1: Are chromatin modifying enzymes the key? Gene 1999; 236:197–208.
Peterson CL. Chromatin remodeling enzymes: Taming the machines. Third in review series on chromatin dynamics. EMBO Reports 2002; 3:319–22.
Nielsen AL, Oulad-Abdelghani M et al. Heterochromatin formation in mammalian cells: Interaction between histones and HP1 proteins. Molecular Cell 2001; 7:729–39.
Galarneau L, Nourani A, Boudreault AA et al. Multiple links between the NuA4 histone acetyltransferase complex and epigenetic control of transcription. Molecular Cell 2000; 5:927–37.
He G, Margolis DM. Counterregulation of chromatin deacetylation and histone deacetylase occupancy at the integrated promoter of human immunodeficiency virus type 1 (HIV-1) by the HIV-1 repressor YY1 and HIV-1 activator Tat. Mol Cell Biol 2002; 22:2965–73.
Yang WM, Inouye C, Zeng Y et al. Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. Proc Natl Acad Sci USA 1996; 93:12845–50.
Rezai-Zadeh N, Zhang X, Namour F et al. Targeted recruitment of a histone H4-specific methyltransferase by the transcription factor YY1. Genes Dev 2003; 17:1019–29.
Shi Y, Sawada J, Sui G et al. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 2003; 422:735–8.
Satijn DP, Hamer KM, den Blaauwen J et al. The polycomb group protein EED interacts with YY1, and both proteins induce neural tissue in Xenopus embryos. Mol Cell Biol 2001; 21:1360–9.
Ogawa H, Ishiguro K, Gaubatz S et al. A complex with chromatin modifiers that occupies E2F-and Myc-responsive genes in G0 cells. Science 2002; 296:1132–6.
Lee JS, Galvin KM, See RH et al. Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev 1995; 9:1188–98.
Coull JJ, Romerio F, Sun JM et al. The human factors YY1 and LSF repress the human immunodeficiency virus type 1 long terminal repeat via recruitment of histone deacetylase 1. J Virol 2000; 74:6790–9.
Osborne A, Zhang H, Yang WM et al. Histone deacetylase activity represses gamma interferon-inducible HLA-DR gene expression following the establishment of a DNase I-hypersensitive chromatin conformation. Mol Cell Biol 2001; 21:6495–506.
Huang NE, Lin CH, Lin YS et al. Modulation of YY1 activity by SAP30. Biochemical & Biophysical Research Communications 2003; 306:267–75.
Yao YL, Yang WM. The metastasis-associated proteins 1 and 2 form distinct protein complexes with histone deacetylase activity. J Biol Chem 2003; 278:42560–8.
Yang WM, Yao YL, Seto E. The FK506-binding protein 25 functionally associates with histone deacetylases and with transcription factor YY1. Embo J 2001; 20:4814–25.
Galasinski SC, Resing KA, Goodrich JA et al. Phosphatase inhibition leads to histone deacetylases 1 and 2 phosphorylation and disruption of corepressor interactions. J Biol Chem 2002; 277:19618–26.
Sewalt RG, Lachner M, Vargas M et al. Selective interactions between vertebrate polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins. Molecular & Cellular Biology 2002; 22:5539–53.
Kuzmichev A, Nishioka K, Erdjument-Bromage H et al. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes & Development 2002; 16:2893–905.
Cao R, Wang L, Wang H et al. Role of histone H3 lysine 27 methylation in Polycomb-group silencing. Science 2002; 298:1039–43.
Wang H, Huang ZQ, Xia L et al. Methylation of histone H4 at arginine 3 facilitating transcriptional activation by nuclear hormone receptor. Science 2001; 293:853–7.
Sewalt RG, Gunster MJ, van der Vlag J et al. C-Terminal binding protein is a transcriptional repressor that interacts with a specific class of vertebrate Polycomb proteins. Molecular & Cellular Biology 1999; 19:777–87.
Seto E, Shi Y, Shenk T. YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro. Nature 1991; 354:241–5.
Usheva A, Shenk T. YY1 transcriptional initiator: Protein interactions and association with a DNA site containing unpaired strands. Proc Natl Acad Sci USA 1996; 93:13571–6.
Usheva A, Shenk T. TATA-binding protein-independent initiation: YY1, TFIIB, and RNA polymerase II direct basal transcription on supercoiled template DNA. Cell 1994; 76:1115–21.
Lee JS, Galvin KM, Shi Y. Evidence for physical interaction between the zinc-finger transcription factors YY1 and Sp1. Proc Natl Acad Sci USA 1993; 90:6145–9.
Seto E, Lewis B, Shenk T. Interaction between transcription factors Sp1 and YY1. Nature 1993; 365:462–4.
Maldonado E, Shiekhattar R, Sheldon M et al. A human RNA polymerase II complex associated with SRB and DNA-repair proteins. [erratum appears in Nature 1996 Nov 28;384(6607):384]. Nature 1996; 381:86–9.
Chiang CM, Roeder RG. Cloning of an intrinsic human TFIID subunit that interacts with multiple transcriptional activators. Science 1995; 267:531–6.
Lee TC, Shi Y, Schwartz RJ. Displacement of BrdUrd-induced YY1 by serum response factor activates skeletal alpha-actin transcription in embryonic myoblasts. Proc Natl Acad Sci USA 1992; 89:9814–8.
Lu SY, Rodriguez M, Liao WS. YY1 represses rat serum amyloid A1 gene transcription and is antagonized by NF-kappa B during acute-phase response. Mol Cell Biol 1994; 14:6253–63.
Gualberto A, LePage D, Pons G et al. Functional antagonism between YY1 and the serum response factor. Mol Cell Biol 1992; 12:4209–14.
Schlisio S, Halperin T, Vidal M et al. Interaction of YY1 with E2Fs, mediated by RYBP, provides a mechanism for specificity of E2F function. Embo J 2002; 21:5775–86.
Galvin KM, Shi Y. Multiple mechanisms of transcriptional repression by YY1. Mol Cell Biol 1997; 17:3723–32.
Bennett MK, Ngo TT, Athanikar JN et al. Co-stimulation of promoter for low density lipoprotein receptor gene by sterol regulatory element-binding protein and Sp1 is specifically disrupted by the yin yang 1 protein. J Biol Chem 1999; 274:13025–32.
Natesan S, Gilman MZ. DNA bending and orientation-dependent function of YY1 in the c-fos promoter. Genes Dev 1993; 7:2497–509.
Kim J, Shapiro DJ. In simple synthetic promoters YY1-induced DNA bending is important in transcription activation and repression. Nucleic Acids Res 1996; 24:4341–8.
Roque MC, Smith PA, Blasquez VC. A developmentally modulated chromatin structure at the mouse immunoglobulin kappa 3′ enhancer. Mol Cell Biol 1996; 16:3138–55.
Kim J, Kollhoff A, Bergmann A et al. Methylation-sensitive binding of transcription factor YY1 to an insulator sequence within the paternally expressed imprinted gene, Peg3. Hum Mol Genet 2003; 12:233–45.
Gaston K, Fried M. CpG methylation has differential effects on the binding of YY1 and ETS proteins to the bi-directional promoter of the Surf-1 and Surf-2 genes. Nucleic Acids Res 1995; 23:901–9.
Hobbs K, Negri J, Klinnert M et al. Interleukin-10 and transforming growth factor-beta promoter polymorphisms in allergies and asthma. Am J Respir Crit Care Med 1998; 158:1958–62.
Pulleyn LJ, Newton R, Adcock IM et al. TGFbeta1 allele association with asthma severity. Hum Genet 2001; 109:623–7.
Costa M, Grant PJ, Rice GI et al. Human endothelial cell-derived nuclear proteins that recognise polymorphic DNA elements in the von Willebrand factor gene promoter include YY1. Thromb Haemost 2001; 86:672–9.
Field JM, Tate LA, Chipman JK et al. Identification of functional regulatory regions of the connexin32 gene promoter. Biochim Biophys Acta 2003; 1628:22–9.
Hines RN, Luo Z, Hopp KA et al. Genetic variability at the human FMO1 locus: Significance of a basal promoter yin yang 1 element polymorphism (FMO1*6). J Pharmacol Exp Ther 2003; 306:1210–8.
de Souza AP, Trevilatto PC, Scarel-Caminaga RM et al. Analysis of the TGF-beta1 promoter polymorphism (C-509T) in patients with chronic periodontitis. J Clin Periodontol 2003; 30:519–23.
Rao A. New functions for DNA binding domains. Sci STKE 2001; 2001:E1.
Lefstin JA, Yamamoto KR. Allosteric effects of DNA on transcriptional regulators. Nature 1998; 392:885–8.
Austen M, Cerni C, Luscher-Firzlaff JM et al. YY1 can inhibit c-Myc function through a mechanism requiring DNA binding of YY1 but neither its transactivation domain nor direct interaction with c-Myc. Oncogene 1998; 17:511–20.
Garcia E, Marcos-Gutierrez C, del Mar Lorente M et al. RYBP, a new repressor protein that interacts with components of the mammalian Polycomb complex, and with the transcription factor YY1. Embo J 1999; 18:3404–18.
Lee JS, Zhang X, Shi Y. Differential interactions of the CREB/ATF family of transcription factors with p300 and adenovirus E1A. J Biol Chem 1996; 271:17666–74.
Sawa C, Yoshikawa T, Matsuda-Suzuki F et al. YEAF1/RYBP and YAF-2 are functionally distinct members of a cofactor family for the YY1 and E4TF1/hGABP transcription factors. J Biol Chem 2002; 277:22484–90.
Kalenik JL, Chen D, Bradley ME et al. Yeast two-hybrid cloning of a novel zinc finger protein that interacts with the multifunctional transcription factor YY1. Nucleic Acids Res 1997; 25:843–9.
Bauknecht T, Angel P, Royer HD et al. Identification of a negative regulatory domain in the human papillomavirus type 18 promoter: Interaction with the transcriptional repressor YY1. Embo J 1992; 11:4607–17.
Bauknecht T, Jundt F, Herr I et al. A switch region determines the cell type-specific positive or negative action of YY1 on the activity of the human papillomavirus type 18 promoter. J Virol 1995; 69:1–12.
Bauknecht T, See RH, Shi Y. A novel C/EBP beta-YY1 complex controls the cell-type-specific activity of the human papillomavirus type 18 upstream regulatory region. J Virol 1996; 70:7695–705.
Yevtodiyenko A, Carr MS, Patel N et al. Analysis of candidate imprinted genes linked to Dlk1-Gtl2 using a congenic mouse line. Mamm Genome 2002; 13:633–8.
Safrany G, Perry RP. Characterization of the mouse gene that encodes the delta/YY1/NF-E1/UCRBP transcription factor. Proc Natl Acad Sci USA 1993; 90:5559–63.
Erkeland SJ, Valkhof M, Heijmans-Antonissen C et al. The gene encoding the transcriptional regulator Yin Yang 1 (YY1) is a myeloid transforming gene interfering with neutrophilic differentiation. Blood 2003; 101:1111–7.
Lee TC, Zhang Y, Schwartz RJ. Bifunctional transcriptional properties of YY1 in regulating muscle actin and c-myc gene expression during myogenesis. Oncogene 1994; 9:1047–52.
Pizzorno MC. Nuclear cathepsin B-like protease cleaves transcription factor YY1 in differentiated cells. Biochim Biophys Acta 2001; 1536:31–42.
Walowitz JL, Bradley ME, Chen S et al. Proteolytic regulation of the zinc finger transcription factor YY1, a repressor of muscle-restricted gene expression. J Biol Chem 1998; 273:6656–61.
Bovolenta C, Camorali L, Lorini AL et al. In vivo administration of recombinant IL-2 to individuals infected by HIV down-modulates the binding and expression of the transcription factors ying-yang-1 and leader binding protein-1/late simian virus 40 factor. J Immunol 1999; 163:6892–7.
Becker KG, Jedlicka P, Templeton NS et al. Characterization of hUCRBP (YY1, NF-E1, delta): A transcription factor that binds the regulatory regions of many viral and cellular genes. Gene 1994; 150:259–66.
Patten M, Wang W, Aminololama-Shakeri S et al. IL-1 beta increases abundance and activity of the negative transcriptional regulatory yin yang-1 (YY1) in neonatal rat cardiac myocytes. J Mol Cell Cardiol 2000; 32:1341–52.
Eliassen KA, Baldwin A, Sikorski EM et al. Role for a YY1-binding element in replication-dependent mouse histone gene expression. Mol Cell Biol 1998; 18:7106–18.
Gordon SJ, Saleque S, Birshtein BK. Yin Yang 1 is a lipopolysaccharide-inducible activator of the murine 3′ Igh enhancer, hs3. J Immunol 2003; 170:5549–57.
Hiromura M, Choi CH, Sabourin NA et al. YY1 is regulated by O-linked N-acetylglucosaminylation (O-glcNAcylation). J Biol Chem 2003; 278:14046–52.
Oei SL, Griesenbeck J, Schweiger M et al. Regulation of RNA Polymerase II-dependent Transcription by Poly(ADP-ribosyl)ation of Transcription Factors. J Biol Chem 1998; 273:31644–31647.
Oei SL, Shi Y. Poly(ADP-ribosyl)ation of transcription factor Yin Yang 1 under conditions of DNA damage. Biochem Biophys Res Commun 2001; 285:27–31.
Oei SL, Griesenbeck J, Schweiger M et al. Interaction of the transcription factor YY1 with human poly(ADP-ribosyl) transferase. Biochem Biophys Res Commun 1997; 240:108–11.
Griesenbeck J, Ziegler M, Tomilin N et al. Stimulation of the catalytic activity of poly(ADP-ribosyl) transferase by transcription factor Yin Yang 1. FEBS Lett 1999; 443:20–4.
Oei SL, Shi Y. Transcription factor Yin Yang 1 stimulates poly(ADP-ribosyl)ation and DNA repair. Biochem Biophys Res Commun 2001; 284:450–4.
Mampuru LJ, Chen SJ, Kalenik JL et al. Analysis of events associated with serum deprivation-induced apoptosis in C3H/Sol8 muscle satellite cells. Exp Cell Res 1996; 226:372–80.
Girton JR, Jeon SH. Novel embryonic and adult homeotic phenotypes are produced by pleiohomeotic mutations in Drosophila. Dev Biol 1994; 161:393–407.
Riggs KJ, Saleque S, Wong KK et al. Yin-yang 1 activates the c-myc promoter. Mol Cell Biol 1993; 13:7487–95.
Wu F, Lee AS. YY1 as a regulator of replication-dependent hamster histone H3.2 promoter and an interactive partner of AP-2. J Biol Chem 2001; 276:28–34.
Johansson E, Hjortsberg K, Thelander L. Two YY-1-binding proximal elements regulate the promoter strength of the TATA-less mouse ribonucleotide reductase R1 gene. J Biol Chem 1998; 273:29816–21.
Labrie C, Lee BH, Mathews MB. Transcription factors RFX1/EF-C and ATF-1 associate with the adenovirus E1A-responsive element of the human proliferating cell nuclear antigen promoter. Nucleic Acids Res 1995; 23:3732–41.
Hehlgans T, Strominger JL. Activation of transcription by binding of NF-E1 (YY1) to a newly identified element in the first exon of the human DR alpha gene. J Immunol 1995; 154:5181–7.
Zabel MD, Wheeler W, Weis JJ et al. Yin Yang 1, Oct1, and NFAT-4 form repeating, cyclosporin-sensitive regulatory modules within the murine CD21 intronic control region. J Immunol 2002; 168:3341–50.
Raich N, Clegg CH, Grofti J et al. GATA1 and YY1 are developmental repressors of the human epsilon-globin gene. Embo J 1995; 14:801–9.
Peters B, Merezhinskaya N, Diffley JF et al. Protein-DNA interactions in the epsilon-globin gene silencer. J Biol Chem 1993; 268:3430–7.
Wandersee NJ, Ferris RC, Ginder GD. Intronic and flanking sequences are required to silence enhancement of an embryonic beta-type globin gene. Mol Cell Biol 1996; 16:236–46.
Jacobsen BM, Skalnik DG. YY1 binds five cis-elements and trans-activates the myeloid cell-restricted gp91(phox) promoter. J Biol Chem 1999; 274:29984–93.
Galvagni F, Cartocci E, Oliviero S. The dystrophin promoter is negatively regulated by YY1 in undifferentiated muscle cells. J Biol Chem 1998; 273:33708–13.
Patten M, Hartogensis WE, Long CS. Interleukin-1beta is a negative transcriptional regulator of alpha1-adrenergic induced gene expression in cultured cardiac myocytes. J Biol Chem 1996; 271:21134–41.
Liu SH, Peng BH, Ma JT et al. Serum response element associated transcription factors in mouse embryos: Serum response factor, YY1, and PEA3 factor. Dev Genet 1995; 16:229–40.
Chen CY, Schwartz RJ. Competition between negative acting YY1 versus positive acting serum response factor and tinman homologue Nkx-2.5 regulates cardiac alpha-actin promoter activity. Mol Endocrinol 1997; 11:812–22.
Kurisaki K, Kurisaki A, Valcourt U et al. Nuclear factor YY1 inhibits transforming growth factor beta-and bone morphogenetic protein-induced cell differentiation. Molecular & Cellular Biology 2003; 23:4494–510.
Kwon HJ, Chung HM. Yin Yang 1, a vertebrate polycomb group gene, regulates antero-posterior neural patterning. Biochem Biophys Res Commun 2003; 306:1008–13.
Raaphorst FM, Otte AP, Meijer CJ. Polycomb-group genes as regulators of mammalian lymphopoiesis. Trends Immunol 2001; 22:682–90.
Brock HW, van Lohuizen M. The Polycomb group—no longer an exclusive club? Current Opinion in Genetics & Development 2001; 11:175–81.
Gould A. Functions of mammalian Polycomb group and trithorax group related genes. Current Opinion in Genetics & Development 1997; 7:488–94.
Kanno M, Hasegawa M, Ishida A et al. mel-18, a Polycomb group-related mammalian gene, encodes a transcriptional negative regulator with tumor suppressive activity. EMBO Journal 1995; 14:5672–8.
Mohd-Sarip A, Venturini F, Chalkley GE et al. Pleiohomeotic can link polycomb to DNA and mediate transcriptional repression. Molecular & Cellular Biology 2002; 22:7473–83.
Mishra RK, Mihaly J, Barges S et al. The iab-7 polycomb response element maps to a nucleosome-free region of chromatin and requires both GAGA and pleiohomeotic for silencing activity. Mol Cell Biol 2001; 21:1311–8.
Trimarchi JM, Fairchild B, Wen J et al. The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex. Proceedings of the National Academy of Sciences of the United States of America 2001; 98:1519–24.
Tan DP, Nonaka K, Nuckolls GH et al. YY1 activates Msx2 gene independent of bone morphogenetic protein signaling. Nucleic Acids Res 2002; 30:1213–23.
Meccia E, Bottero L, Felicetti F et al. HOXB7 expression is regulated by the transcription factors NF-Y, YY1, Sp1 and USF-1. Biochim Biophys Acta 2003; 1626:1–9.
Gilthorpe J, Vandromme M, Brend T et al. Spatially specific expression of Hoxb4 is dependent on the ubiquitous transcription factor NFY. Development 2002; 129:3887–99.
O’Carroll D, Erhardt S, Pagani M et al. The polycomb-group gene Ezh2 is required for early mouse development. Mol Cell Biol 2001; 21:4330–6.
Faust C, Lawson KA, Schork NJ et al. The Polycomb-group gene eed is required for normal morphogenetic movements during gastrulation in the mouse embryo. Development 1998; 125:4495–506.
Lessard J, Schumacher A, Thorsteinsdottir U et al. Functional antagonism of the Polycomb-Group genes eed and Bmi1 in hemopoietic cell proliferation. Genes Dev 1999; 13:2691–703.
Su IH, Basavaraj A, Krutchinsky AN et al. Ezh2 controls B cell development through histone H3 methylation and Igh rearrangement. Nat Immunol 2003; 4:124–31.
Lessard J, Sauvageau G, Kwon HJ et al. Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis. Exp Hematol 2003; 31:567–85.
Zalani S, Coppage A, Holley-Guthrie E et al. The cellular YY1 transcription factor binds a cis-acting, negatively regulating element in the Epstein-Barr virus BRLF1 promoter. J Virol 1997; 71:3268–74.
Dong X, Liu H, Pfister H. YY1 and its repressive effect on human papillomavirus 16 early promoter P97 existed widely among human epithelial cell lines. Chinese Journal of Experimental & Clinical Virology 1998; 12:217–22.
Weill L, Shestakova E, Bonnefoy E. Transcription factor YY1 binds to the murine beta interferon promoter and regulates its transcriptional capacity with a dual activator/repressor role. J Virol 2003; 77:2903–14.
Moriuchi M, Moriuchi H, Margolis DM et al. USF/c-Myc enhances, while Yin-Yang 1 suppresses, the promoter activity of CXCR4, a coreceptor for HIV-1 entry. J Immunol 1999; 162:5986–92.
Moriuchi M, Moriuchi H. YY1 transcription factor down-regulates expression of CCR5, a major co-receptor for HIV-1. J Biol Chem 2003; 5:5.
Cristillo AD, Bierer BE. Regulation of CXCR4 expression in human T lymphocytes by calcium and calcineurin. Mol Immunol 2003; 40:539–53.
Margolis DM, Somasundaran M, Green MR. Human transcription factor YY1 represses human immunodeficiency virus type 1 transcription and virion production. J Virol 1994; 68:905–10.
Romerio F, Gabriel MN, Margolis DM. Repression of human immunodeficiency virus type 1 through the novel cooperation of human factors YY1 and LSF. J Virol 1997; 71:9375–82.
Lee D, Kim H, Lee Y et al. Identification of sequence requirement for the origin of DNA replication in human papillomavirus type 18. Virus Res 1997; 52:97–108.
Lee KY, Broker TR, Chow LT. Transcription factor YY1 represses cell-free replication from human papillomavirus origins. J Virol 1998; 72:4911–7.
Park JS, Hwang ES, Lee CJ et al. Mutational and functional analysis of HPV-16 URR derived from Korean cervical neoplasia. Gynecol Oncol 1999; 74:23–9.
O’Connor MJ, Tan SH, Tan CH et al. YY1 represses human papillomavirus type 16 transcription by quenching AP-1 activity. J Virol 1996; 70:6529–39.
Schmidt M, Kedzia W, Gozdzicka-Jozefiak A. Intratype HPV16 sequence variation within LCR of isolates from asymptomatic carriers and cervical cancers. J Clin Virol 2001; 23:65–77.
Veress G, Murvai M, Szarka K et al. Transcriptional activity of human papillomavirus type 16 variants having deletions in the long control region. Eur J Cancer 2001; 37:1946–52.
Stephen AL, Thompson CH, Tattersall MH et al. Analysis of mutations in the URR and E6/E7 oncogenes of HPV 16 cervical cancer isolates from central China. Int J Cancer 2000; 86:695–701.
Kozuka T, Aoki Y, Nakagawa K et al. Enhancer-promoter activity of human papillomavirus type 16 long control regions isolated from cell lines SiHa and CaSki and cervical cancer biopsies. Jpn J Cancer Res 2000; 91:271–9.
Dong XP, Stubenrauch F, Beyer-Finkler E et al. Prevalence of deletions of YY1-binding sites in episomal HPV 16 DNA from cervical cancers. Int J Cancer 1994; 58:803–8.
May M, Dong XP, Beyer-Finkler E et al. The E6/E7 promoter of extrachromosomal HPV16 DNA in cervical cancers escapes from cellular repression by mutation of target sequences for YY1. Embo J 1994; 13:1460–6.
Parija T, Das BR. Involvement of YY1 and its correlation with c-myc in NDEA induced hepatocarcinogenesis, its prevention by d-limonene. Mol Biol Rep 2003; 30:41–6.
Nayak BK, Das BR. Differential binding of NF1 transcription factor to P53 gene promoter and its depletion in human breast tumours. Mol Biol Rep 1999; 26:223–30.
Kalantari M, Blennow E, Hagmar B et al. Physical state of HPV16 and chromosomal mapping of the integrated form in cervical carcinomas. Diagn Mol Pathol 2001; 10:46–54.
Yengi L, Inskip A, Gilford J et al. Polymorphism at the glutathione S-transferase locus GSTM3: Interactions with cytochrome P450 and glutathione S-transferase genotypes as risk factors for multiple cutaneous basal cell carcinoma. Cancer Res 1996; 56:1974–7.
Rose BR, Thompson CH, Zhang J et al. Sequence variation in the upstream regulatory region of HPV 18 isolates from cervical cancers. Gynecol Oncol 1997; 66:282–9.
Shrivastava A, Saleque S, Kalpana GV et al. Inhibition of transcriptional regulator Yin-Yang-1 by association with c-Myc. Science 1993; 262:1889–92.
Austen M, Cerni C, Henriksson M et al. Regulation of cell growth by the Myc-Max-Mad network: Role of Mad proteins and YY1. Curr Top Microbiol Immunol 1997; 224:123–30.
Shrivastava A, Yu J, Artandi S, Calame K. YY1 and c-Myc associate in vivo in a manner that depends on c-Myc levels. Proc Natl Acad Sci USA 1996; 93:10638–41.
Wang J, Mager J, Chen Y et al. Imprinted X inactivation maintained by a mouse Polycomb group gene. Nat Genet 2001; 28:371–5.
Klenova EM, Fagerlie S, Filippova GN et al. Characterization of the chicken CTCF genomic locus, and initial study of the cell cycle-regulated promoter of the gene. J Biol Chem 1998; 273:26571–9.
Furlong EE, Rein T, Martin F. YY1 and NF1 both activate the human p53 promoter by alternatively binding to a composite element, and YY1 and E1A cooperate to amplify p53 promoter activity. Mol Cell Biol 1996; 16:5933–45.
Gabellini D, Green MR, Tupler R. Inappropriate gene activation in FSHD: A repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 2002; 110:339–48.
Romey MC, Pallares-Ruiz N, Mange A et al. A naturally occurring sequence variation that creates a YY1 element is associated with increased cystic fibrosis transmembrane conductance regulator gene expression. J Biol Chem 2000;275:3561–7
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Landes Bioscience/Eurekah.com and Kluwer Academic/Plenum Publishers
About this chapter
Cite this chapter
Liu, H., Shi, Y. (2005). Yin Yang 1. In: Iuchi, S., Kuldell, N. (eds) Zinc Finger Proteins. Molecular Biology Intelligence Unit. Springer, Boston, MA. https://doi.org/10.1007/0-387-27421-9_25
Download citation
DOI: https://doi.org/10.1007/0-387-27421-9_25
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-48229-8
Online ISBN: 978-0-387-27421-8
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)